Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 194

Related Citations for PubMed (Select 15319670)

1.

Tolerability and safety of HIV protease inhibitors in adults.

Sax PE, Kumar P.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1111-24. Review. Erratum in: J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1434.

PMID:
15319670
2.

Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.

Tsiodras S, Mantzoros C, Hammer S, Samore M.

Arch Intern Med. 2000 Jul 10;160(13):2050-6.

PMID:
10888979
3.

HIV-1 protease inhibitors.

Eron JJ Jr.

Clin Infect Dis. 2000 Jun;30 Suppl 2:S160-70. Review.

4.

Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors.

Melvin AJ, Lennon S, Mohan KM, Purnell JQ.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1117-23.

PMID:
11522181
5.

Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.

Jones R, Sawleshwarkar S, Michailidis C, Jackson A, Mandalia S, Stebbing J, Bower M, Nelson M, Gazzard BG, Moyle GJ.

HIV Med. 2005 Nov;6(6):396-402.

PMID:
16268821
6.

Lipodystrophy in patients with HIV-1 infection: effect of stopping protease inhibitors on TNF-alpha and TNF-receptor levels, and on metabolic parameters.

Maher B, Lloyd J, Wilkins EG, Fraser WD, Back D, Park BK, Pirmohamed M.

Antivir Ther. 2004 Dec;9(6):879-87.

PMID:
15651746
7.

[Lipid disorders in patients with HIV-induced diseases].

Chanu B, Valensi P.

Presse Med. 2005 Sep 10;34(15):1087-94. Review. French.

PMID:
16334888
8.

Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.

[No authors listed]

Prescrire Int. 2004 Aug;13(72):144-50.

PMID:
15532140
9.
10.

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.

Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chmiel JS, Visscher BR, Margolick JB, Dobs AS.

AIDS. 2005 Sep 2;19(13):1375-83.

PMID:
16103768
11.

Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.

Moreno-Torres A, Domingo P, Pujol J, Blanco-Vaca F, Arroyo JA, Sambeat MA.

Antivir Ther. 2007;12(2):195-203.

PMID:
17503662
12.

[HIV-lipodystrophy syndrome].

Mauss S, Schmutz G.

Med Klin (Munich). 2001 Jul 15;96(7):391-401. Review. German.

PMID:
11494914
14.

Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.

Fantoni M, Del Borgo C, Autore C, Barbaro G.

Ital Heart J. 2002 May;3(5):294-9. Review.

PMID:
12066561
15.

Cutaneous toxicities of antiretroviral therapy for HIV: part I. Lipodystrophy syndrome, nucleoside reverse transcriptase inhibitors, and protease inhibitors.

Introcaso CE, Hines JM, Kovarik CL.

J Am Acad Dermatol. 2010 Oct;63(4):549-61; quiz 561-2. doi: 10.1016/j.jaad.2010.01.061. Review.

PMID:
20846563
16.

Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.

Gougeon ML, Pénicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J.

Antivir Ther. 2004 Apr;9(2):161-77. Review.

PMID:
15134178
17.

[Metabolic disturbances associated with HAART].

Olczak A.

Przegl Epidemiol. 2007;61(4):639-46. Review. Polish.

PMID:
18572495
18.

Appearance-related side effects of HIV-1 treatment.

Hawkins T.

AIDS Patient Care STDS. 2006 Jan;20(1):6-18. Review.

PMID:
16426151
19.

Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men.

Ware LJ, Jackson AG, Wootton SA, Burdge GC, Morlese JF, Moyle GJ, Jackson AA, Gazzard BG.

Br J Nutr. 2009 Oct;102(7):1038-46. doi: 10.1017/S0007114509338817. Epub 2009 Jun 1.

PMID:
19480729
20.

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

Negredo E, Paredes R, Bonjoch A, Tuldrà A, Fumaz CR, Gel S, Garcés B, Johnston S, Arnó A, Balagué M, Jou A, Tural C, Sirera G, Romeu J, Cruz L, Francia E, Domingo P, Arrizabalaga J, Ruiz I, Arribas JR, Ruiz L, Clotet B.

Antivir Ther. 1999;4 Suppl 3:23-8.

PMID:
16021868
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk